Literature DB >> 23712800

Recovery after copper-deficiency myeloneuropathy in Wilson's disease.

Tiago Teodoro, Dulce Neutel, Patrícia Lobo, Ana F Geraldo, Isabel Conceição, Mário M Rosa, Luísa Albuquerque, Joaquim J Ferreira.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23712800     DOI: 10.1007/s00415-013-6963-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  5 in total

1.  EASL Clinical Practice Guidelines: Wilson's disease.

Authors: 
Journal:  J Hepatol       Date:  2012-03       Impact factor: 25.083

2.  Zinc-induced copper deficiency in Wilson disease.

Authors:  J Horvath; P Beris; E Giostra; P-Y Martin; P R Burkhard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10-04       Impact factor: 10.154

3.  Copper deficiency myeloneuropathy in a patient with Wilson disease.

Authors:  F P da Silva-Júnior; A A C Machado; L T Lucato; E L R Cançado; E R Barbosa
Journal:  Neurology       Date:  2011-05-10       Impact factor: 9.910

4.  Copper deficiency in Wilson's disease: peripheral neuropathy and myelodysplastic syndrome complicating zinc treatment.

Authors:  Andrea Cortese; Roberta Zangaglia; Alessandro Lozza; Giovanni Piccolo; Claudio Pacchetti
Journal:  Mov Disord       Date:  2011-03-29       Impact factor: 10.338

5.  Axonal sensory motor neuropathy in copper-deficient Wilson's disease.

Authors:  Alexandra Foubert-Samier; Annabelle Kazadi; Marie Rouanet; Anne Vital; Alain Lagueny; François Tison; Wassilios Meissner
Journal:  Muscle Nerve       Date:  2009-08       Impact factor: 3.217

  5 in total
  1 in total

Review 1.  Bioavailable Trace Metals in Neurological Diseases.

Authors:  Aurélia Poujois; Jean-Christophe Devedjian; Caroline Moreau; David Devos; Pascal Chaine; France Woimant; James A Duce
Journal:  Curr Treat Options Neurol       Date:  2016-10       Impact factor: 3.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.